BioClub has broad resource network in China including 200,000+ entrepreneurs, 10,000+ startup companies, 500+ investment institutions, 1200+ investors, 1500+ industry KOLs, 100+ listed/unicorn companies. BioClub also manages RMB 400 million angels Funds and has totally invested 35+ medical projects. 

In addition, BioClub’s shareholders are very influential in the industry including 3 founders of listed companies and 4 leading investment institutions in China.

BioClub builds strategic partnership with AstraZeneca, Fosun Pharm, China Resources Group, Meinian Health, BGI, China Life Insurance, Taikang Life Insurance, Lepu Medical, TigerMed, Tasly, Dean Diagnostics, Conba Pharm, IFLYTEK, CEC Data, Century, PingAn Technology, Andon Medical，TellGen, UEC Group, Deloitte, Minsheng Pharm, Baheal Pharm, BabyTree, CBT Pharm, West China Hospital, The First Affiliated Hospital of Zhejiang University, The Second Affiliated Hospital of Zhejiang University, The Eye Hospital of Wenzhou Medical University.

BioClub has strong qualification of technology transfer and incubation, it is the first batch of “Maker Space” of the Ministry of Science and Technology in 2015, and the “National Technology Transfer Demonstration Organization” of Torch Center of the Ministry of Science and Technology in 2014.

The innovative model and rapid development of BioClub is highly praised by Chinese top leaders such as Li Yuanchao, former Vice President of the State, Liu Yandong, former Vice Premier of the State Council, Wan Gang, former Minister of Science and Technology, Lin Nianxiu, Deputy Director of the National Development and Reform Commission, Cao Jianlin, former Vice Minister of the Ministry of Science and Technology, Che Jun, Secretary of Zhejiang Provincial Committee and Li Qiang，former Governor of Zhejiang Provincial.

BioClub 贝壳社

Org chart

Teams

Offices

BioClub 贝壳社

Org chart

Teams

Offices

Related companies